Open AccessP675: TREATMENT OF HYPERTENSION IN PATIENTS RECEIVING BTK INHIBITORS: A MULTICENTER RETROSPECTIVE STUDY
Author(s) -
Shadman M.,
Voutsinas J.,
Fakhri B.,
Khajavian S.,
Spurgeon S.,
Stephens D.,
Skarnbik A.,
Mato A.,
Broome C.,
Gopal A.,
Smith S.,
Lynch R.,
Rainey M.,
Kim S.,
BarrettCampbell O.,
Hemond E.,
Tsang M.,
Ermann D.,
Malakhov N.,
Rao D.,
Shakib Azar M.,
Morrigan B.,
Chauhan A.,
Plate T.,
Gooley T.,
Ryan K.,
Lansigan F.,
Hill B.,
Pongas G.,
Parikh S.,
Roeker L.,
Allan J.,
Cheng R.,
Ujjani C.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845584.91358.28
Subject(s) - medicine , ibrutinib , drug class , adverse effect , blood pressure , retrospective cohort study , drug , pharmacology , chronic lymphocytic leukemia , leukemia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom